Literature DB >> 25001860

Innate immune cell networking in hepatitis C virus infection.

Banishree Saha1, Gyongyi Szabo2.   

Abstract

Persistent viral infection, such as HCV infection, is the result of the inability of the host immune system to mount a successful antiviral response, as well as the escape strategies devised by the virus. Although each individual component of the host immune system plays important roles in antiviral immunity, the interactive network of immune cells as a whole acts against the virus. The innate immune system forms the first line of host defense against viral infection, and thus, virus elimination or chronic HCV infection is linked to the direct outcome of the interactions between the various innate immune cells and HCV. By understanding how the distinct components of the innate immune system function both individually and collectively during HCV infection, potential therapeutic targets can be identified to overcome immune dysfunction and control chronic viral infection.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  NK cells; chronic; dendritic cells; macrophages; monocytes; sensors

Mesh:

Year:  2014        PMID: 25001860      PMCID: PMC4197565          DOI: 10.1189/jlb.4MR0314-141R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  136 in total

Review 1.  Cross-talk between dendritic cells and natural killer cells in viral infection.

Authors:  Daniel M Andrews; Christopher E Andoniou; Anthony A Scalzo; Serani L H van Dommelen; Morgan E Wallace; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

Review 2.  Structural mechanism of RNA recognition by the RIG-I-like receptors.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

3.  Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.

Authors:  Randy S Longman; Andrew H Talal; Ira M Jacobson; Charles M Rice; Matthew L Albert
Journal:  J Infect Dis       Date:  2005-06-27       Impact factor: 5.226

Review 4.  Pathophysiological roles of interleukin-18 in inflammatory liver diseases.

Authors:  H Tsutsui; K Matsui; H Okamura; K Nakanishi
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

5.  Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

Authors:  Nan Wang; Yuqiong Liang; Santhana Devaraj; Jie Wang; Stanley M Lemon; Kui Li
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

6.  IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Authors:  Shuye Zhang; Banishree Saha; Karen Kodys; Gyongyi Szabo
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

7.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

Authors:  Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

8.  Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Authors:  Shuye Zhang; Karen Kodys; Kui Li; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2012-10-23       Impact factor: 22.682

Review 9.  Toll-like receptors in antiviral innate immunity.

Authors:  Sandra N Lester; Kui Li
Journal:  J Mol Biol       Date:  2013-12-03       Impact factor: 5.469

10.  Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Authors:  Takayuki Abe; Yuuki Kaname; Itsuki Hamamoto; Yoshimi Tsuda; Xiaoyu Wen; Shuhei Taguwa; Kohji Moriishi; Osamu Takeuchi; Taro Kawai; Tatsuya Kanto; Norio Hayashi; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more
  22 in total

1.  CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.

Authors:  Chelsey J Judge; Lenche Kostadinova; Kenneth E Sherman; Adeel A Butt; Yngve Falck-Ytter; Nicholas T Funderburg; Alan L Landay; Michael M Lederman; Scott F Sieg; Johan K Sandberg; Donald D Anthony
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

2.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

3.  Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Authors:  Anupam Mukherjee; Adrian M Di Bisceglie; Ratna B Ray
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 4.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

Review 5.  Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-09-08

6.  Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments.

Authors:  Elisabetta Cariani; Massimo Pilli; Valeria Barili; Emanuela Porro; Elisabetta Biasini; Andrea Olivani; Raffaele Dalla Valle; Tommaso Trenti; Carlo Ferrari; Gabriele Missale
Journal:  Oncoimmunology       Date:  2016-03-04       Impact factor: 8.110

7.  Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection.

Authors:  Sukriti Sukriti; Nirupma Trehanpati; Manoj Kumar; Chandana Pande; Syed S Hissar; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2016-09-22       Impact factor: 6.047

Review 8.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

Review 9.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 10.  Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C.

Authors:  Andrea Crosignani; Antonio Riva; Silvia Della Bella
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.